最終更新日：2025/11/30
Researchers reported that briakinumab reduced joint swelling and improved mobility in several rheumatoid arthritis patients during the Phase II trial.
正解を見る
Researchers reported that briakinumab reduced joint swelling and improved mobility in several rheumatoid arthritis patients during the Phase II trial.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
